Clinical Trials Sponsored by Lowcountry Infectious Diseases

Total 3839 results

Lowcountry Infectious Diseases

Unknown

Neuroma Injections to Treat Restless Legs Syndrome - RCT

Restless Legs Syndrome

United States
Bamrasnaradura Infectious Diseases Institute
Department of Disease Control, Thailand

Completed

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure (BIDI-MONO)

HIV | AIDS | Treatment Failure | Lopinavir

Thailand
ANRS, Emerging Infectious Diseases

Not yet recruiting

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. (CABOPrEP)

Prevention

France
ANRS, Emerging Infectious Diseases

Recruiting

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia (HEPEDIAC)

HCV Infection

Cambodia
ANRS, Emerging Infectious Diseases

Recruiting

Aging With HIV and Neurocognitive Decline, a Follow-up Study (AgingHAND)

HIV Infections

France
ANRS, Emerging Infectious Diseases

Recruiting

Prevention of Mental Health Problems Among Persons Without Personal Housing in the Context of the COVID-19 Epidemic (RESPOND-FR)

Quality of Life | Psychological Distress | Psychosocial Intervention

France
ANRS, Emerging Infectious Diseases

Not yet recruiting

Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns (IPOP)

Mother to Child HIV Transmission
ANRS, Emerging Infectious Diseases

Recruiting

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Covid19 | SARS-CoV Infection

France
ANRS, Emerging Infectious Diseases

Not yet recruiting

Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection

HIV I Infection
ANRS, Emerging Infectious Diseases

Completed

Health and Migration Trajectories of Housekeepers in Bamako (2DM2K)

HIV Infections | Hepatitis B | Hepatitis C | Tuberculosis | STIs | Sex Behavior

Mali
ANRS, Emerging Infectious Diseases

Completed

DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) (DRIVE-C)

Hepatitis C | Viral Hepatitis C | Drug Use

Vietnam
ANRS, Emerging Infectious Diseases

Terminated

Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial (AMEP-EHVA T02)

HIV Seropositivity

Switzerland
ANRS, Emerging Infectious Diseases

Completed

A Community-based Intervention Among Active Drug Users in Montpellier (ICONE)

Drug Use | HCV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire (PRECO-CI)

HIV Infection

Côte D'Ivoire
ANRS, Emerging Infectious Diseases

Completed

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 (STATIS)

HIV-1 Infection

Vietnam, Cambodia, Côte D'Ivoire, Uganda
ANRS, Emerging Infectious Diseases

Completed

Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety

Growth and Development

Burkina Faso, South Africa, Uganda, Zambia
Janssen Infectious Diseases BVBA

Completed

A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics

Human Immunodeficiency Virus Type 1

Belgium
ANRS, Emerging Infectious Diseases

Completed

Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? (TRANSBioHIV)

HIV Infection

France
Janssen Infectious Diseases BVBA

Approved for marketing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Tuberculosis

Russian Federation, Lithuania
ANRS, Emerging Infectious Diseases

Completed

Evaluation of Raltegravir During the Third Trimester of Pregnancy (ANRS 160 RalFE)

HIV-1 Infection | PREGNANCY

France
ANRS, Emerging Infectious Diseases

Completed

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

HIV | Viral Hepatitis C

France
ANRS, Emerging Infectious Diseases

Completed

Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients (DARULIGHT)

HIV INFECTION

France
ANRS, Emerging Infectious Diseases

Completed

National Evaluation of PI-based 2nd Line Efficacy in Cambodia

HIV

Cambodia
ANRS, Emerging Infectious Diseases

Completed

Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients (ANRS ECHAM)

HIV Infection | Liver Injuries

France, Germany, Belgium
Janssen Infectious Diseases BVBA

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Hepatitis C Virus Infection

United States, Canada
ANRS, Emerging Infectious Diseases

Completed

4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients (ANRS162-4D)

HIV-1 Infection

France
ANRS, Emerging Infectious Diseases

Completed

X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study (X LIBRIS)

Hiv Infection

France
ANRS, Emerging Infectious Diseases

Unknown

Qualification of Point-of-Care Assays for Management of HCV Patients (ANRS HC POC)

Hepatitis C

France
Janssen Infectious Diseases BVBA

Completed

A Study to Assess the Relative Bioavailability of TMC207 Following Single-Dose Administrations of Two Pediatric Formulations in Healthy Adult Participants

Healthy | Biological Availability

Netherlands
Bamrasnaradura Infectious Diseases Institute

Completed

Ritonavir-boosted Lopinavir Monotherapy

HIV

Thailand
Bamrasnaradura Infectious Diseases Institute

Completed

Nevirapine Levels and Fluconazole

Adverse Event | Nevirapine | Fluconazole
ANRS, Emerging Infectious Diseases

Not yet recruiting

Study Evaluating the Safety, in Terms of HBV Virological Control at 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected With the HIV-1 and HBV Viruses (BI-LIGHT)

HIV Infections | HBV Coinfection
Vancouver Infectious Diseases Centre

Recruiting

Eliminating HCV Infection Among PWUD

Hepatitis C, Chronic | Drug Use

Canada
ANRS, Emerging Infectious Diseases

Recruiting

Primary Infection Cohort (PRIMO)

HIV-1-infection

France
ANRS, Emerging Infectious Diseases

Recruiting

Prevention of HIV in "Île-de-France" (ANRS-PREVENIR)

HIV Infections

France
ANRS, Emerging Infectious Diseases

Recruiting

the ANRS CO21 " Extreme " Cohort (CODEX) (CODEX)

HIV Infection

France
ANRS, Emerging Infectious Diseases

Unknown

Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men (APACHES)

Hiv Infection

France
Vancouver Infectious Diseases Centre

Unknown

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed

Drug Use | Human Immunodeficiency Virus I Infection

Canada
ANRS, Emerging Infectious Diseases

Completed

Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity ("ImmunoCo27")

HIV Infection
ANRS, Emerging Infectious Diseases

Completed

Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir

Hepatitis C
ANRS, Emerging Infectious Diseases

Completed

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men (IPERGAY)

HIV Infection

France, Canada
ANRS, Emerging Infectious Diseases

Completed

Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon

HIV Infections

Cameroon
ANRS, Emerging Infectious Diseases

Completed

Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers (VRI01)

HIV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

HIV-1

Senegal
Janssen Infectious Diseases BVBA

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

Hepatitis C Virus Infection

United States, Canada
Janssen Infectious Diseases BVBA

Withdrawn

A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Multi-drug Resistant Tuberculosis

China, Ukraine, Taiwan, Korea, Republic of, Peru, Brazil, Estonia, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey, Georgia, Mexico, Cambodia, Ethiopia
ANRS, Emerging Infectious Diseases

Completed

Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study (EP48 HIV CHEST)

Lung Cancer | Hiv Infection

France
ANRS, Emerging Infectious Diseases

Completed

Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination (ANRSHBEP03)

HIV Infection | Hepatitis B

France
ANRS, Emerging Infectious Diseases

Unknown

Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV) (Lympho C)

Chronic Hepatitis C

France
Janssen Infectious Diseases BVBA

Completed

A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

Hepatic Impairment

Germany, Czech Republic

3

Subscribe